Prognostic role of controlling nutritional status score in hematological malignancies

References

• Yilmaz M, Atilla FD, Sahin F, et al. The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy. Support Care Cancer. 2020;28(3):1441–1448.
   PubMed Web of Science ®Google Scholar
• Xu LB, Shi MM, Huang ZX, et al. Impact of malnutrition diagnosed using global leadership initiative on malnutrition criteria on clinical outcomes of patients with gastric cancer. JPEN J Parenter Enteral Nutr. 2022;46(2):385–394.
   PubMed Web of Science ®Google Scholar
• de Sousa IM, Silva FM, de Carvalho A, et al. Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: a prospective study. JPEN J Parenter Enteral Nutr. 2022;46(3):508–516.
   PubMed Web of Science ®Google Scholar
• Nikniaz Z, Somi MH, Naghashi S. Malnutrition and weight loss as prognostic factors in the survival of patients with gastric cancer. Nutr Cancer. 2022: 1–6.
   PubMed Web of Science ®Google Scholar
• Mancuso S, Mattana M, Santoro M, et al. Host-related factors and cancer: malnutrition and non-Hodgkin lymphoma. Hematol Oncol. 2022.
   PubMed Web of Science ®Google Scholar
• Matsukawa T, Suto K, Kanaya M, et al. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020;99(12):2859–2868.
   PubMed Web of Science ®Google Scholar
• Yan D, Shen Z, Zhang S, et al. Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with diffuse large B-cell lymphoma. J Cancer. 2021;12(23):7010–7017.
   PubMed Web of Science ®Google Scholar
• Kamath SK, Lawler M, Smith AE, et al. Hospital malnutrition: a 33-hospital screening study. J Am Diet Assoc. 1986;86(2):203–206.
   PubMedGoogle Scholar
• Ulíbarri J, Villar N, Giménez GM, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutrición Hospitalaria. 2005;20(1):38–45.
   Google Scholar
• Formiga F, Chivite D, Corbella X. Utility of the controlling nutritional status (CONUT) score in patients admitted due to acute heart failure. Int J Cardiol. 2017;235(undefined):203.
   PubMedGoogle Scholar
• Kato T, Yaku H, Morimoto T, et al. Association with controlling nutritional status (CONUT) score and In-hospital mortality and infection in acute heart failure. Sci Rep. 2020;10(1):3320.
   PubMed Web of Science ®Google Scholar
• Ahiko Y, Shida D, Horie T, et al. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer. 2019;19(1):946.
   PubMed Web of Science ®Google Scholar
• Takagi K, Buettner S, Ijzermans J. Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2020;78(undefined):91–96.
   PubMedGoogle Scholar
• Peng W, Yao M, Zou K, et al. Postoperative controlling nutritional status score is an independent risk factor of survival for patients with small hepatocellular carcinoma: a retrospective study. BMC Surg. 2021;21(1):338.
   PubMed Web of Science ®Google Scholar
• Imai D, Maeda T, Shimokawa M, et al. Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection. Hepatol Res. 2020;50(1):101–109.
   PubMed Web of Science ®Google Scholar
• Kuroda D, Sawayama H, Kurashige J, et al. Controlling nutritional status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204–212.
   PubMed Web of Science ®Google Scholar
• Jeon CH, Park KB, Jung YJ, et al. Modified controlling nutritional status score: A refined prognostic indicator depending on the stage of gastric cancer. Surg Oncol. 2020;34(undefined):261–269.
   PubMedGoogle Scholar
• Takemura K, Yuasa T, Fujiwara R, et al. Prognostic significance of the controlling nutritional status (CONUT) score in patients with advanced renal cell carcinoma treated with nivolumab after failure of prior tyrosine kinase inhibitors. J Urol. 2020;204(6):1166–1172.
   PubMed Web of Science ®Google Scholar
• Niu X, Zhu Z, Bao J. Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta-analysis. Cancer Cell Int. 2021;21(1):126.
   PubMed Web of Science ®Google Scholar
• Nagata A, Kanemasa Y, Sasaki Y, et al. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma. Hematol Oncol. 2020;38(3):309–317.
   PubMed Web of Science ®Google Scholar
• Baysal M, Bas V, Demirci U, et al. The utility of CONUT score in diffuse large B cell lymphoma patients. Niger J Clin Pract. 2021;24(8):1194–1199.
   PubMed Web of Science ®Google Scholar
• Zhou X, Lu Y, Xia J, et al. Association between baseline controlling nutritional status score and clinical outcomes of patients with multiple myeloma. Cancer Biomark. 2021;32(1):65–71.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Ureshino H, Kidoguchi K, et al. Clinical impact of the CONUT score in patients with multiple myeloma. Ann Hematol. 2020;99(1):113–119.
   PubMed Web of Science ®Google Scholar
• Kamiya T, Ito C, Fujita Y, et al. The prognostic value of the controlling nutritional status score in patients with multiple myeloma. Leuk Lymphoma. 2020;61(8):1894–1900.
   PubMed Web of Science ®Google Scholar
• Park S, Han B, Cho JW, et al. Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Nutr Cancer. 2014;66(2):225–233.
   PubMed Web of Science ®Google Scholar
• Ureshino H, Kusaba K, Kidoguchi K, et al. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Ann Hematol. 2019;98(2):465–471.
   PubMed Web of Science ®Google Scholar
• Senjo H, Onozawa M, Hidaka D, et al. A novel nutritional index “simplified CONUT” and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia. Sci Rep. 2020;10(1):19400.
   PubMed Web of Science ®Google Scholar
• Sakurai A, Nakazato T. The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia related changes treated with azacitidine. Leuk Lymphoma. 2020;61(12):2995–2997.
   PubMed Web of Science ®Google Scholar
• Song H, Xu B, Luo C, et al. The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study. Cancer Manag Res. 2019;11:7567–7575.
   PubMed Web of Science ®Google Scholar
• Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33(26):2863–2869.
   PubMed Web of Science ®Google Scholar
• Wei X, Zheng J, Zhang Z, et al. Consecutive hypoalbuminemia predicts inferior outcome in patients with diffuse large B-cell lymphoma. Front Oncol. 2020;10(undefined):610681.
   PubMedGoogle Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
   PubMed Web of Science ®Google Scholar
• Bairey O, Shacham-Abulafia A, Shpilberg O, et al. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematol Oncol. 2016;34(4):184–192.
   PubMed Web of Science ®Google Scholar
• Dalia S, Chavez J, Little B, et al. Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Ann Hematol. 2014;93(8):1305–1312.
   PubMed Web of Science ®Google Scholar
• Marini A, Carulli G, Azzara A, et al. Serum cholesterol and triglycerides in hematological malignancies. Acta Haematol. 1989;81(2):75–79.
   PubMed Web of Science ®Google Scholar
• Gao R, Liang JH, Wang L, et al. Low serum cholesterol levels predict inferior prognosis and improve NCCN-IPI scoring in diffuse large B cell lymphoma. Int J Cancer. 2018;143(8):1884–1895.
   PubMed Web of Science ®Google Scholar
• Muller CP, Wagner AU, Maucher C, et al. Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemia. Eur J Haematol. 1989;43(3):235–239.
   PubMed Web of Science ®Google Scholar
• Cucuianu A, Malide D, Petrov L, et al. Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies. Rom J Intern Med. 1992;30(4):261–268.
   PubMedGoogle Scholar
• Sok M, Ravnik J, Ravnik M. Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer. Wien Klin Wochenschr. 2009;121(9-10):314–317.
   PubMed Web of Science ®Google Scholar
• Li B, Huang D, Zheng H, et al. Preoperative serum total cholesterol is a predictor of prognosis in patients with renal cell carcinoma: a meta- analysis of observational studies. Int Braz J Urol. 2020;46(2):158–168.
   PubMed Web of Science ®Google Scholar
• Shivakumar L, Ansell S. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies. Clin Lymphoma Myeloma. 2006;7(2):106–108.
   PubMedGoogle Scholar
• Aoki K, Tabata S, Yonetani N, et al. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. Acta Haematol. 2013;130(4):242–246.
   PubMed Web of Science ®Google Scholar
• Vahamurto P, Pollari M, Clausen MR, et al. Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large B-cell lymphoma. Cancers (Basel). 2020;12(7), 1967. Undefined.
   PubMed Web of Science ®Google Scholar
• Ko SM, Lee J, Bae SJ, et al. Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients. Br J Cancer. 2021;125(1):119–125.
   PubMed Web of Science ®Google Scholar
• Joseph N, McWilliam A, Kennedy J, et al. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy. Radiother Oncol. 2019;135:115–119.
   PubMed Web of Science ®Google Scholar
• Mehrazin R, Uzzo RG, Kutikov A, et al. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2015;33(9):388.e19–388.e25.
   PubMed Web of Science ®Google Scholar
• Feng J, Wang Z, Guo X, et al. Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis. Int J Hematol. 2012;95(2):143–148.
   PubMed Web of Science ®Google Scholar
• Lewis WD, Lilly S, Jones KL. Lymphoma: diagnosis and treatment. Am Fam Physician. 2020;101(1):34–41.
   PubMed Web of Science ®Google Scholar
• Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2005;23(18):4117–4126.
   PubMed Web of Science ®Google Scholar
• Ruppert AS, Dixon JG, Salles G, et al. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 2020;135(23):2041–2048.
   PubMed Web of Science ®Google Scholar
• Allen PB, Pro B. Therapy of peripheral T cell lymphoma: focus on nodal subtypes. Curr Oncol Rep. 2020;22(5):44.
   PubMed Web of Science ®Google Scholar
• Nakamura N, Kanemura N, Lee S, et al. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma. Leuk Lymphoma. 2021: 1–8.
   PubMed Web of Science ®Google Scholar
• van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410–427.
   PubMed Web of Science ®Google Scholar
• Greipp PR, San MJ, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412–3420.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548.
   PubMed Web of Science ®Google Scholar
• Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464–477.
   PubMed Web of Science ®Google Scholar
• Yang QK, Su YN, Wang W, et al. CONUT score or/and peripheral blood CD4+/CD8+ ratio-based web dynamic nomograms to predict the individualized survival of patients with advanced osteosarcoma. Cancer Manag Res. 2020;12:4193–4208.
   PubMed Web of Science ®Google Scholar
• Li YQ, Wang Y, Song Y, et al. [The influence of CONUT score on the prognosis of patients with multiple myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29(3):781–786.
   PubMedGoogle Scholar
• Liang F, Dong XY, Tang GF, et al. [Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi. 2021;42(4):332–337.
   PubMedGoogle Scholar
• Juliusson G, Hough R. Leukemia. Prog Tumor Res. 2016;43(undefined):87–100.
   PubMedGoogle Scholar
• Bispo J, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):a34819.
   PubMed Web of Science ®Google Scholar